FINAL RESULTS AND PHARMACOECONOMIC ANALYSIS OF A TRIAL COMPARING TWO NEOADJUVANT CHEMOTHERAPY (CT) REGIMENS FOLLOWED BY SURGERY IN PATIENTS WITH RESECTABLE NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE II RANDOMISED STUDY BY THE EUROPEAN LUNG CANCER WORKING PARTY

被引：0
|
作者：
Berghmans, Thierry
Lafitte, Jean-Jacques [1 ]
Giner, Vicente
Berchier, Marie-Claude
Scherpereel, Arnaud [1 ]
Lewin, Daniel
Paesmans, Marianne
Meert, Anne-Pascale
Bosschaerts, Thierry [2 ]
Leclercq, Nathalie
Sculier, Jean-Paul
机构：
[1] CHRU Lille, Lille, France
[2] Hop St Pierre, St Pierre, Belgium
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
Non small cell lung carcinoma; Surgery; neoadjuvant chemotherapy; Cost-effectiveness;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S465 / S466
页数：2
相关论文
共 50 条
  • [41] Study on Predictive Factors of Anti-Angiogenesis Therapy Combined with Neoadjuvant Chemotherapy for Phase IIIA Non-Small Cell Lung Cancer
    Wang, Changli
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S771 - S771
  • [42] Effectiveness of neoadjuvant immunochemotherapy compared to neoadjuvant chemotherapy in non-small cell lung cancer patients: Real-world data of a retrospective, dual-center study
    Fei, Kailun
    Guo, Gang
    Wang, Jie
    Wang, Zhijie
    Wang, Yan
    Hao, Xuezhi
    Zhong, Jia
    Guo, Qinxiang
    Guo, Wei
    Su, Wenzhong
    Zan, Likun
    Xu, Jiaxi
    Tan, Fengwei
    Zhuang, Xiaofei
    Duan, Jianchun
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [43] Phase II trial of induction chemotherapy with carboplatin and paclitaxel plus bevacizumab in patients with stage IIIA to IV nonsquamous non-small cell lung cancer
    Imai, Kazuhiro
    Nakagawa, Taku
    Matsuzaki, Ikuo
    Orino, Kimito
    Saito, Hajime
    Sato, Kazuhiro
    Sano, Masaaki
    Nakayama, Katsutoshi
    Sato, Yusuke
    Motoyama, Satoru
    Nomura, Kyoko
    Shibata, Hiroyuki
    Minamiya, Yoshihiro
    SURGERY TODAY, 2019, 49 (08) : 678 - 685
  • [44] Cost-effectiveness analysis of neoadjuvant versus adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer patients during initial treatment phase
    Dongdong Wu
    Juan Li
    Yubo Wang
    Hao Huang
    Chunji Huang
    Cost Effectiveness and Resource Allocation, 19
  • [45] Phase II study of carboplatin, docetaxel and bevacizumab for chemotherapy-naive patients with advanced non-squamous non-small cell lung cancer
    Takiguchi, Yuichi
    Iwasawa, Shunichiro
    Minato, Koichi
    Miura, Yosuke
    Gemma, Akihiko
    Noro, Rintaro
    Yoshimori, Kozo
    Shingyoji, Masato
    Hino, Mitsunori
    Ando, Masahiro
    Okamoto, Hiroaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (04) : 659 - 667
  • [46] Cost-effectiveness analysis of neoadjuvant versus adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer patients during initial treatment phase
    Wu, Dongdong
    Li, Juan
    Wang, Yubo
    Huang, Hao
    Huang, Chunji
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2021, 19 (01)
  • [47] Postoperative radiotherapy improves survival of patients with ypN2 non-small cell lung cancer after neoadjuvant chemotherapy followed by surgery - A propensity score matching study of the Surveillance, Epidemiology, and End Results database
    Bao, Yongxing
    Yang, Xu
    Men, Yu
    Kang, Jingjing
    Sun, Xin
    Zhao, Maoyuan
    Sun, Shuang
    Yuan, Meng
    Ma, Zeliang
    Hui, Zhouguang
    THORACIC CANCER, 2022, 13 (03) : 404 - 411
  • [48] Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC)
    Baumann, M.
    Herrmann, T.
    Koch, R.
    Matthiessen, W.
    Appold, S.
    Wahlers, B.
    Kepka, L.
    Marschke, G.
    Feltl, D.
    Fietkau, R.
    Budach, V.
    Dunst, J.
    Dziadziuszko, R.
    Krause, M.
    Zips, D.
    RADIOTHERAPY AND ONCOLOGY, 2011, 100 (01) : 76 - 85
  • [49] Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS)
    Gralla, Richard J.
    Edelman, Martin J.
    Detterbeck, Frank C.
    Jahan, Thierry M.
    Loesch, David M.
    Limentani, Steven A.
    Govindan, Ramaswamy
    Peng, Guangbin
    Monberg, Matthew J.
    Obasaju, Coleman K.
    Socinski, Mark A.
    SUPPORTIVE CARE IN CANCER, 2009, 17 (03) : 307 - 313
  • [50] A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer:: interim analysis
    Santo, A
    Pedersini, R
    Pasini, F
    Terzi, A
    Pari, F
    Cartei, G
    Sibau, A
    Molino, A
    Maiorino, A
    Panza, N
    Oletti, MV
    Maluta, S
    Calabrò, F
    Cetto, GL
    LUNG CANCER, 2001, 34 : S15 - S20
12345